Cargando…
Immunochemotherapy includes pembrolizumab for stage IIIB lung squamous cell carcinoma: a case report
BACKGROUND: Lung cancer is a malignant tumor with high morbidity and mortality, and its incidence continues to increase. With the emergence of new drugs and treatment modalities, the prognosis of lung cancer patients has improved to some extent. However, the prognosis of initially unresectable, loca...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577729/ https://www.ncbi.nlm.nih.gov/pubmed/36267777 http://dx.doi.org/10.21037/atm-22-3769 |